跳至主要内容
临床试验/ITMCTR2100005212
ITMCTR2100005212招募中未知

Real world study on adjuvant treatment of non-small cell lung cancer with commonly used anti-cancer traditional Chinese medicine injection

Beijing Hospital of Traditional Chinese Medicined0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

性别
All

入选标准

  • (1) Patients with primary lung cancer hospitalized in the oncology department of Beijing Traditional Chinese medicine hospital from January 1, 2016 to December 31, 2018 according to the standardized diagnosis and treatment guidelines;
  • (2) The patients were treated with platinum containing double drug chemotherapy for more than 2 cycles;
  • (3) Traditional Chinese medicine injection and Kang'ai injection were used simultaneously in chemotherapy.

排除标准

  • At the same time, there are other primary malignant tumors; Lung tumor metastases from other sites to the lung; Pathological diagnosis was small cell lung cancer.

研究者

发起方
Beijing Hospital of Traditional Chinese Medicined

相似试验